Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593

Pharmacology, Toxicology and Pharmaceutical Science

• Cannabinoid 1 Receptor 100%
• Positive Allosteric Modulator 100%
• Disease 14%
• Binding Site 14%
• Glaucoma 14%
• Allosteric Modulator 14%
• Huntington Chorea 14%
• Structure Activity Relationship 14%

Immunology and Microbiology

• Enantiomer 100%
• Agonist 33%
• Immune Disorder 16%
• Binding Site 16%
• Structure Activity Relation 16%

Keyphrases

• Pharmacological Evaluation 100%
• Immune Disorders 12%
• Glaucoma Disease 12%
• Biochemical Activity 12%